Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Adenosine A2 receptor modulation of erythropoietin secretion in hepatocellular carcinoma cells.

Nakashima J, Brookins J, Ohigashi T, Fisher JW.

Life Sci. 1994;54(2):109-17. Erratum in: Life Sci 1994;54(11):751.

PMID:
8123156
2.

Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production.

Nakashima J, Ohigashi T, Brookins JW, Beckman BS, Agrawal KC, Fisher JW.

Kidney Int. 1993 Oct;44(4):734-40.

3.

[Increase in erythropoietin secretion mediated by adenosine A2 receptors].

Nakashima J, Tazaki H, Fisher JW.

Hum Cell. 1993 Mar;6(1):36-41. Japanese.

PMID:
8393698
4.

Adenosine A1 receptors and erythropoietin production.

Ohigashi T, Brookins J, Fisher JW.

Am J Physiol. 1993 Oct;265(4 Pt 1):C934-8.

PMID:
8238318
5.

Enhancement of erythropoietin production by selective adenosine A2 receptor agonists in response to hypoxia.

Ohigashi T, Nakashima J, Aggarwal S, Brookins J, Agrawal K, Fisher JW.

J Lab Clin Med. 1995 Sep;126(3):299-306.

PMID:
7665979
6.

A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Alexander SP, Curtis AR, Kendall DA, Hill SJ.

Br J Pharmacol. 1994 Dec;113(4):1501-7.

7.

Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.

Bruns RF, Lu GH, Pugsley TA.

Mol Pharmacol. 1986 Apr;29(4):331-46.

PMID:
3010074
8.

Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine.

Nakashima J, Brookins J, Beckman B, Fisher JW.

Am J Physiol. 1991 Sep;261(3 Pt 1):C455-60.

PMID:
1653522
9.

In vivo and in vitro erythropoietin activities in cultures of a hepatocellular carcinoma cell line.

Nakashima J, Brookins J, Beckman B, Ohigashi T, Fisher JW.

Proc Soc Exp Biol Med. 1993 May;203(1):84-91.

PMID:
8386383
10.

Differential development of adenosine A1 and A2b receptors in the rat duodenum.

Peachey JA, Hourani SM, Kitchen I.

Br J Pharmacol. 1996 Nov;119(5):949-58.

11.
12.
13.

Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.

Mazzoni MR, Buffoni RS, Giusti L, Lucacchini A.

J Recept Signal Transduct Res. 1995 Sep-Dec;15(7-8):905-29.

PMID:
8673723
14.

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.

Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.

Br J Pharmacol. 1997 Jun;121(3):353-60.

15.

A1 and A2 adenosine receptors in rabbit cortical collecting tubule cells. Modulation of hormone-stimulated cAMP.

Arend LJ, Sonnenburg WK, Smith WL, Spielman WS.

J Clin Invest. 1987 Mar;79(3):710-4.

16.

Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.

Br J Pharmacol. 1996 Apr;117(7):1381-6.

17.

Characterization of 5'-N-ethylcarboxamido[3H]adenosine binding to pig aorta smooth muscle membranes.

Diocee BK, Souness JE.

Biochem Pharmacol. 1987 Nov 1;36(21):3621-7.

PMID:
2823828
18.

Characterization of A-2 receptors in postmortem human pineal gland.

Reynaud D, Gharib A, Lagarde M, Sarda N.

J Neurochem. 1990 Oct;55(4):1316-21.

PMID:
2398360
19.

Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells.

Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ.

Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H650-6.

20.

Activation of multiple sites by adenosine analogues in the rat isolated aorta.

Prentice DJ, Hourani SM.

Br J Pharmacol. 1996 Jul;118(6):1509-17.

Supplemental Content

Support Center